ES2148171T3 - Gen mutado en cancer colorrectal de humanos. - Google Patents

Gen mutado en cancer colorrectal de humanos.

Info

Publication number
ES2148171T3
ES2148171T3 ES92905276T ES92905276T ES2148171T3 ES 2148171 T3 ES2148171 T3 ES 2148171T3 ES 92905276 T ES92905276 T ES 92905276T ES 92905276 T ES92905276 T ES 92905276T ES 2148171 T3 ES2148171 T3 ES 2148171T3
Authority
ES
Spain
Prior art keywords
mcc
humans
colorectal cancer
mutated gene
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92905276T
Other languages
English (en)
Inventor
Bert Vogelstein
Kenneth W Kinzler
Raymond L White
Yusuke Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japanese Foundation for Cancer Research
Johns Hopkins University
University of Utah
Original Assignee
Japanese Foundation for Cancer Research
Johns Hopkins University
University of Utah
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japanese Foundation for Cancer Research, Johns Hopkins University, University of Utah filed Critical Japanese Foundation for Cancer Research
Application granted granted Critical
Publication of ES2148171T3 publication Critical patent/ES2148171T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE DESCUBRE UN NUEVO GEN HUMANO DENOMINADO MCC. SE PROVEEN METODOS Y EQUIPOS PARA DETERMINAR MUTACIONES DEL GEN MCC EN TEJIDOS HUMANOS Y MUESTRAS CORPORALES. EN CELULAS DE TUMOR HUMANO SE OBSERVAN RECOMPOSICION INTEGRA Y MUTACIONES PUNTUALES. MCC SE EXPRESA EN LA MAYORIA DE LOS TEJIDOS NORMALES. ESTOS RESULTADOS SUGIEREN QUE MCC ES UN SUPRESOR DE TUMOR.
ES92905276T 1991-03-13 1992-01-16 Gen mutado en cancer colorrectal de humanos. Expired - Lifetime ES2148171T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/670,611 US5330892A (en) 1991-03-13 1991-03-13 MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans

Publications (1)

Publication Number Publication Date
ES2148171T3 true ES2148171T3 (es) 2000-10-16

Family

ID=24691103

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92905276T Expired - Lifetime ES2148171T3 (es) 1991-03-13 1992-01-16 Gen mutado en cancer colorrectal de humanos.

Country Status (11)

Country Link
US (5) US5330892A (es)
EP (1) EP0580596B1 (es)
JP (1) JP3501802B2 (es)
AT (1) ATE194660T1 (es)
AU (1) AU664834B2 (es)
CA (1) CA2105876A1 (es)
DE (1) DE69231245T2 (es)
DK (1) DK0580596T3 (es)
ES (1) ES2148171T3 (es)
GR (1) GR3034446T3 (es)
WO (1) WO1992016656A1 (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330892A (en) * 1991-03-13 1994-07-19 The Johns Hopkins University MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans
JP3633932B2 (ja) 1992-04-01 2005-03-30 ザ ジョーンズ ホプキンズ ユニバーシティー スクール オブ メディシン 糞便試料から単離した哺乳類の核酸を検出する方法、およびその検出用試薬
US7326778B1 (en) * 1993-05-05 2008-02-05 The John Hopkins University Mutator gene and hereditary non-polyposis colorectal cancer
EP0700446A1 (en) * 1993-05-26 1996-03-13 The Johns Hopkins University Antibodies specific for dcc gene product
US5962220A (en) * 1993-10-26 1999-10-05 Thomas Jefferson University Compositions that specifically bind to colorectal cells and methods of using the same
US5879656A (en) * 1993-10-26 1999-03-09 Thomas Jefferson University Methods of treating metastatic colorectal cancer with ST receptor binding compounds
US7097839B1 (en) * 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
DE4431174A1 (de) * 1994-09-01 1996-03-07 Deutsches Krebsforsch Nachweisverfahren für tumorspezifische mRNA
US5891629A (en) * 1995-09-28 1999-04-06 Ambion, Inc. Compositions for improving RNase cleavage of base pair mismatches in double-stranded nucleic acids
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5741650A (en) * 1996-01-30 1998-04-21 Exact Laboratories, Inc. Methods for detecting colon cancer from stool samples
US6242212B1 (en) * 1996-02-09 2001-06-05 Thomas Jefferson University Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins
US5858673A (en) * 1996-06-24 1999-01-12 Charlotte-Mecklenburg Hospital Authority Method for detecting prostate cells
US6300077B1 (en) 1996-08-14 2001-10-09 Exact Sciences Corporation Methods for the detection of nucleic acids
US6203993B1 (en) 1996-08-14 2001-03-20 Exact Science Corp. Methods for the detection of nucleic acids
US6100029A (en) * 1996-08-14 2000-08-08 Exact Laboratories, Inc. Methods for the detection of chromosomal aberrations
US5952178A (en) 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6146828A (en) * 1996-08-14 2000-11-14 Exact Laboratories, Inc. Methods for detecting differences in RNA expression levels and uses therefor
US6020137A (en) * 1996-08-14 2000-02-01 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US6268136B1 (en) 1997-06-16 2001-07-31 Exact Science Corporation Methods for stool sample preparation
US6406857B1 (en) 1997-06-16 2002-06-18 Exact Sciences Corporation Methods for stool sample preparation
US6120995A (en) * 1997-08-07 2000-09-19 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US7135333B1 (en) 1997-08-07 2006-11-14 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US20020064792A1 (en) * 1997-11-13 2002-05-30 Lincoln Stephen E. Database for storage and analysis of full-length sequences
US6897018B1 (en) 1998-02-25 2005-05-24 The United States Of America As Represented By The Department Of Health And Human Services DLC-1 gene deleted in cancers
US7226731B1 (en) 1998-07-24 2007-06-05 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services PB 39, a gene dysregulated in prostate cancer, and uses thereof
AU5128799A (en) * 1998-07-24 2000-02-14 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Pb 39, a gene dysregulated in prostate cancer, and uses thereof
US6503718B2 (en) 1999-01-10 2003-01-07 Exact Sciences Corporation Methods for detecting mutations using primer extension for detecting disease
US6280947B1 (en) 1999-08-11 2001-08-28 Exact Sciences Corporation Methods for detecting nucleotide insertion or deletion using primer extension
ES2269102T3 (es) 1999-02-25 2007-04-01 Exact Sciences Corporation Procedimientos para conservar la integridad del adn.
DE60029092T2 (de) 1999-04-09 2007-02-01 Exact Sciences Corp., Marlborough Verfahren zur detektion von nukleinsäuren, welche auf krebs hinweisen
US6586177B1 (en) * 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US7368233B2 (en) * 1999-12-07 2008-05-06 Exact Sciences Corporation Methods of screening for lung neoplasm based on stool samples containing a nucleic acid marker indicative of a neoplasm
US6919174B1 (en) 1999-12-07 2005-07-19 Exact Sciences Corporation Methods for disease detection
CA2404428A1 (en) * 2000-03-27 2001-10-04 Thomas Jefferson University High specificity marker detection
US7923205B2 (en) * 2000-08-25 2011-04-12 Toshikazu Shiba Method for protecting personal information
US6428964B1 (en) 2001-03-15 2002-08-06 Exact Sciences Corporation Method for alteration detection
US7776524B2 (en) * 2002-02-15 2010-08-17 Genzyme Corporation Methods for analysis of molecular events
US20040259101A1 (en) * 2003-06-20 2004-12-23 Shuber Anthony P. Methods for disease screening
CA2586515A1 (en) * 2003-11-05 2005-05-26 Exact Sciences Corporation Repetitive reversed-field affinity electrophoresis and uses therefor
WO2005071404A1 (en) * 2004-01-23 2005-08-04 Garvan Institute Of Medical Research Methods of diagnosing colorectal cancer and reagents therefor
WO2005111244A2 (en) * 2004-05-10 2005-11-24 Exact Sciences Corporation Methods for detecting a mutant nucleic acid
US20080124714A1 (en) * 2004-05-14 2008-05-29 Exact Sciences Corporation Method for Stabilizing Biological Samples for Nucleic Acid Analysis
WO2006026654A2 (en) * 2004-08-27 2006-03-09 Exact Sciences Corporation Method for detecting a recombinant event
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
WO2007044071A2 (en) * 2005-04-21 2007-04-19 Exact Sciences Corporation Analysis of heterogeneous nucleic acid samples
US11286519B2 (en) 2013-12-11 2022-03-29 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
US11859246B2 (en) 2013-12-11 2024-01-02 Accuragen Holdings Limited Methods and compositions for enrichment of amplification products
SG11201604737VA (en) 2013-12-11 2016-07-28 Accuragen Inc Compositions and methods for detecting rare sequence variants
KR20180055905A (ko) 2015-10-09 2018-05-25 아큐라젠 홀딩스 리미티드 증폭 산물의 농축을 위한 방법 및 조성물
CA3024630A1 (en) 2016-05-16 2017-11-23 Accuragen Holdings Limited Method of improved sequencing by strand identification
CN109844133A (zh) 2016-08-15 2019-06-04 安可济控股有限公司 检测罕见序列变体的组合物和方法
US11203782B2 (en) 2018-03-29 2021-12-21 Accuragen Holdings Limited Compositions and methods comprising asymmetric barcoding
CN115963268B (zh) * 2023-02-14 2023-09-19 浙江大学 一种用于结直肠癌早期诊断的血浆分泌蛋白组合及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU625169B2 (en) * 1987-03-23 1992-07-02 Imperial Chemical Industries Plc Molecular markers
JPH03505675A (ja) * 1988-10-31 1991-12-12 ザ リージェンツ オブ ザ ユニヴァーシティ オブ カリフォルニア 新生表現型の抑制を制御する産生体及び方法
US5352775A (en) * 1991-01-16 1994-10-04 The Johns Hopkins Univ. APC gene and nucleic acid probes derived therefrom
US5330892A (en) * 1991-03-13 1994-07-19 The Johns Hopkins University MCC gene (mutated in colorectal cancer) used for diagnosis of cancer in humans
US5411860A (en) * 1992-04-07 1995-05-02 The Johns Hopkins University Amplification of human MDM2 gene in human tumors

Also Published As

Publication number Publication date
US5571905A (en) 1996-11-05
EP0580596A1 (en) 1994-02-02
AU1330292A (en) 1992-10-21
GR3034446T3 (en) 2000-12-29
JP3501802B2 (ja) 2004-03-02
US5576422A (en) 1996-11-19
CA2105876A1 (en) 1992-09-14
EP0580596B1 (en) 2000-07-12
DK0580596T3 (da) 2000-10-30
ATE194660T1 (de) 2000-07-15
DE69231245T2 (de) 2001-02-01
JPH06509701A (ja) 1994-11-02
US5830676A (en) 1998-11-03
DE69231245D1 (de) 2000-08-17
US5330892A (en) 1994-07-19
US5693536A (en) 1997-12-02
WO1992016656A1 (en) 1992-10-01
AU664834B2 (en) 1995-12-07

Similar Documents

Publication Publication Date Title
ES2148171T3 (es) Gen mutado en cancer colorrectal de humanos.
DE69231734D1 (de) Geerbte und somatische mutationen des apc-gens bei menschlichem colorectal-krebs
ATE238554T1 (de) Krebsbehandlung
EP0772456A4 (en) DIAGNOSIS AND TREATMENT OF CELL PROLIFERATION DISEASES IN WHICH CLONAL MACROPHAGES ARE INVOLVED
EP0390323A3 (en) Detection of loss of the wild-type p53 gene
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
CY1110029T1 (el) Γονιδιο που εκφραζεται στον καρκινο του προστατη
DK0507852T3 (da) Gen deleteret hos mennesker med kolorektal cancer
WO2000004149A3 (en) Compositions and methods for therapy and diagnosis of prostate cancer
EA199900349A1 (ru) Каталитическая субъединица теломеразы человека
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
EP2261369A3 (en) Gene expression profiling in biopsied tumor tissues
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
EP1767636A3 (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
MX9708401A (es) Genes reguladores de la cromatina.
BR0110091A (pt) Composições e processos para terapia e diagnóstico de câncer de mama
DE60032784D1 (de) Markerproteine für prostatakrebs
WO2003070889A3 (en) Prostate specific genes and the use thereof in design or therapeutics
ATE323176T1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
Vazquez-Mazariego et al. Cytogenetic study of neuroendocrine carcinoma of Merkel cells
SADAHIRO et al. A CLINICOPATHOLOGICAL STUDY OF CASES WITH CANCER OF UNKNOWN ORIGIN ANALYSIS OF CELLULAR PROTEINS IN PRIMARY AND METASTATIC CANCEROUS TISSUE
DE69839846D1 (de) Bestimmung der vorhandenen mengen an cyclin-abhängr bei krebspatienten
YU5002A (sh) Jedinjenja i postupci za lečenje i dijagnozu raka pluća
DE68911305T2 (de) Das lungenwachstum stimulierende und hemmende faktoren für krebstumorzellen.
TR200200691T2 (tr) Akciğer kanserinin tedavisine ve teşhisine ilişkin bileşimler

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 580596

Country of ref document: ES